Podcast Episodes

Back to Search
The Tesla Playbook for Success (ft. Former President Jon McNeill)

Episode 217: Today, Ann revisits her March conversation with Jon McNeill, former President of Tesla and Co-Founder & CEO of DVx Ventures. Jon unpacks…

3 months, 1 week ago

Short Long
View Episode
Fighting for the Biggest IPOs (ft. Nasdaq Vice Chairman)
Fighting for the Biggest IPOs (ft. Nasdaq Vice Chairman)

Episode 1216: Today, Ann revisits her January conversation with Bob McCooey, Vice Chairman of the Nasdaq. Recorded before the SpaceX IPO, they discus…

3 months, 1 week ago

Short Long
View Episode
When Legacy Brands Don't Survive Disruption (ft. Jacob Goldstein)
When Legacy Brands Don't Survive Disruption (ft. Jacob Goldstein)

Episode 215: Today, we step back from the headlines to explore one of the biggest questions in business: How does an industry leader stay on top when…

3 months, 1 week ago

Short Long
View Episode
Micron’s Memory Crunch Hits Consumers & Alexa+ Goes Shopping
Micron’s Memory Crunch Hits Consumers & Alexa+ Goes Shopping

Episode 214: Today, we survey Micron's blockbuster earnings, what they reveal about the next phase of the AI buildout and the ripple effect being fel…

3 months, 1 week ago

Short Long
View Episode
The Power Plant in Your House & Cashing In on the World Cup
The Power Plant in Your House & Cashing In on the World Cup

Episode 213: Today, we survey a new partnership between Tesla, Sunrun Solar and Renew Home that aims to turn millions of American homes into a single…

3 months, 2 weeks ago

Short Long
View Episode
Solving Crypto’s Volatility Problem & Today’s Tech Sell-Off
Solving Crypto’s Volatility Problem & Today’s Tech Sell-Off

Episode 212: Today, we explore the global factors that precipitated today’s tech sell-off and which chip stocks to keep an eye on this week. Then, w…

3 months, 2 weeks ago

Short Long
View Episode
Big Pharma’s “Patent Cliff” & Overheard on Earnings
Big Pharma’s “Patent Cliff” & Overheard on Earnings

Episode 211: Today, John digs into why pharma giant AbbVie is writing a $10.9 billion check for a clinical-stage company with no approved drugs and n…

3 months, 2 weeks ago

Short Long
View Episode
This CEO Bet Everything on OpenDoor (ft. Kaz Nejatian)
This CEO Bet Everything on OpenDoor (ft. Kaz Nejatian)

Episode 210: Turnarounds are tough – especially as a public company where investors are watching every move. Today, Ann sits down with Kaz Nejatian, …

3 months, 2 weeks ago

Short Long
View Episode
The New Fed Playbook & Rebuilding Aging Internet Icons
The New Fed Playbook & Rebuilding Aging Internet Icons

Episode 209: Today, we survey the latest Fed rate decision and its new approach to communicating under Chair Kevin Warsh. Then, we spin through the h…

3 months, 3 weeks ago

Short Long
View Episode
SpaceX Goes Shopping & Prediction Markets: Investing or Betting?
SpaceX Goes Shopping & Prediction Markets: Investing or Betting?

Episode 208: Today, Ann surveys SpaceX's $60 billion acquisition of AI coding platform Cursor and what it suggests about SPCX’s new life as a public …

3 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us